-
公开(公告)号:DE2941597A1
公开(公告)日:1981-04-23
申请号:DE2941597
申请日:1979-10-13
Applicant: BASF AG
Inventor: FRICKEL FRITZ-FRIEDER DIPL CHE , FRANKE ALBRECHT DIPL CHEM DR , PHILIPSBORN GERDA VON DR MED , MUELLER CLAUS D DR MED , LENKE DIETER PROF DR
IPC: A61K31/40 , A61K31/403 , A61K31/404 , A61K31/4427 , A61K31/445 , A61K31/454 , A61K31/47 , A61P9/00 , A61P9/06 , C07C271/22 , C07D207/34 , C07D207/36 , C07D209/42 , C07D401/12 , C07D401/14
Abstract: Substituted piperidinoalkyl ethers of 4,5-dialkyl-3-hydroxy-pyrrole-2-carboxylic acid esters and their physiologically tolerated addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:DE3732094A1
公开(公告)日:1989-04-06
申请号:DE3732094
申请日:1987-09-24
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , BINNIG FRITZ DR , PHILIPSBORN GERDA VON DR MED
IPC: A61K31/435 , A61K31/44 , A61P9/06 , C07D471/08
Abstract: Bispidine derivatives of the formula I I where R, R1 and R3 are identical or different and are each H, C1-C4-alkyl, halogen or C1-C4-alkoxy, when Y is R2 is C1-C4-alkyl, halogen, -CN, C1-C4-alkoxy, -NHSO2CH3, -CF3, NH-acetyl or -NR4R5 where R4 and R5 are each C1-C4-alkyl, when Y is R2 is C1-C4-alkyl, halogen, -CN1C1-C4-alkoxy, -NHSO2CH3, -CF3, NH-acetyl or -NR9R10 where R9 is C1-C4-alkyl and R10 is H or C1-C4-alkyl, and when X is not CH2 R2 may also be NO2 or NH2, X is -CH2-, -C(O)- or -C(R6)OR7- (where R6 is H or C1-C4-alkyl and R7 is H, C1-C4-alkyl or where R8 is H, C1-C4-alkyl, halogen or C1 -C4-alkoxy), Y is -C(O) or -CONH- and Z is C1-C4-alkylene which may be olefinically unsaturated and/or branched, and their physiologically tolerated salts, and drugs containing these compounds as active compounds are described.
-
公开(公告)号:DE2734882A1
公开(公告)日:1979-02-22
申请号:DE2734882
申请日:1977-08-03
Applicant: BASF AG
IPC: A61K31/425 , A61K31/505 , C07D275/04 , C07D417/10
Abstract: 3-[4-(1,3-Diazacyclo-2-yl)]-1,2-benzisothiazoles, their addition salts with acids, their manufacture, and pharmaceutical formulations which contain these compounds as active ingredients and which may be used for the pharmacotherapy of cardiac arrhythmias.
-
公开(公告)号:DE4036782A1
公开(公告)日:1992-05-21
申请号:DE4036782
申请日:1990-11-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , PHILIPSBORN GERDA VON DR MED , SCHULT SABINE DR , KIRCHENGAST MICHAEL DR
IPC: A61K31/165 , A61K31/00 , A61K31/16 , A61K31/167 , A61K31/40 , A61K31/445 , A61K31/4453 , A61P9/00 , A61P9/06 , C07C233/29 , C07C235/38 , C07D295/08 , C07D295/088 , C07D295/092
Abstract: Substituted anilides of the formula I I (where R1 is C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, halogen, cyano, nitro, C2-C4-alkenyl, C2-C4-alkynyl; X is methylene, ethylene, vinylene; R2 and R3 are each C1-C4-alkyl, C3-C6-cycloalkyl or together are tetra- or pentamethylene; R4 is C1-C4-alkyl, methoxy; n is 2, 3 or 4), and the physiologically tolerated acid addition salts thereof, the pharmaceutical use thereof, drugs produced therefrom and the use thereof for treating cardiac arrhythmias and/or for lowering the heart rate, are described.
-
公开(公告)号:DE3825559A1
公开(公告)日:1990-02-01
申请号:DE3825559
申请日:1988-07-28
Applicant: BASF AG
IPC: A61K31/135 , A61K31/13 , A61K31/395 , A61K31/40 , A61K31/445 , A61P9/06 , C07C217/22 , C07D295/08 , C07D295/092
Abstract: p-Hydroxyphenone derivatives of the general formula I … … in which R , R and R are identical or different and are methyl, chlorine, bromine and hydrogen, where R , R and R are not all H, R and R are identical or different and are H, C1-C4-alkyl or OR , where R and R are not both H, X is a -CH=CH-, -CH2CH2- and -CH2-bridge, Y is a straight-chain or branched, saturated or unsaturated C1-C4-bridge and Z is the radical NR R , where R and R are, independently of one another, hydrogen or C1-C4-alkyl, or Z is a 5- or 6-membered ring with a nitrogen atom in position 1 and, where appropriate, additionally a second N or an O or S atom, where the second N atom is substituted by R , the physiologically tolerated salts thereof, and medicaments prepared therefrom and the use thereof as Vaughan-Williams Class III antiarrhythmic.
-
公开(公告)号:DE2711655A1
公开(公告)日:1978-09-21
申请号:DE2711655
申请日:1977-03-17
Applicant: BASF AG
IPC: A61C8/00 , A61K31/435 , A61K31/44 , A61K31/4406 , A61K31/4415 , A61K31/4418 , A61K31/4427 , A61K31/445 , A61K31/455 , A61K31/495 , A61K31/496 , A61P9/00 , A61P9/04 , A61P9/06 , C07D213/127 , C07D213/65 , C07D213/66 , C07D213/67 , C07D213/79 , C07D213/80 , C07D221/04 , C07D263/32 , C07D401/12 , C07D471/04 , C07D491/04 , C07D491/048 , C07D491/056
Abstract: New pyridinyl aminoalkyl ethers, their N-oxides and their physiologically acceptable addition salts with acids, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful in the treatment of cardiac arrhythmias.
-
公开(公告)号:DE3725273A1
公开(公告)日:1989-02-09
申请号:DE3725273
申请日:1987-07-30
Applicant: BASF AG
Inventor: FRANKE ALBRECHT DR , SCHLECKER RAINER DR , GRIES JOSEF DR MED , PHILIPSBORN GERDA VON DR MED , UNGER LILIANE DR
IPC: A61K31/135 , A61P9/06 , A61P25/02
Abstract: The agents are prepared as described and used for certain groups of patients.
-
公开(公告)号:DE2950064A1
公开(公告)日:1981-06-19
申请号:DE2950064
申请日:1979-12-13
Applicant: BASF AG
Inventor: FRICKEL FRITZ-FRIEDER DIPL CHE , PHILIPSBORN GERDA VON DR MED , MUELLER CLAUS D DR MED , LENKE DIETER PROF DR
IPC: A61K31/4433 , A61K31/445 , A61P9/06 , C07D333/38 , C07D409/12 , A61K31/38
Abstract: Substituted piperidino-alkyl ethers of 3-hydroxy-thiophene-2-carboxylic acid esters and their physiologically tolerated addition salts with acids, processes for their preparation, and pharmaceutical formulations which contain these compounds and which may be used in the treatment of cardiac arrhythmias.
-
公开(公告)号:DE2841074A1
公开(公告)日:1980-04-03
申请号:DE2841074
申请日:1978-09-21
Applicant: BASF AG
Inventor: ALBRECHT HANS PETER DIPL CHEM , PHILIPSBORN GERDA VON DR MED , SIEBENEICK HANS ULRICH DIPL CH , RASCHACK MANFRED DR
IPC: A61K31/704 , A61P9/04 , C07J19/00 , C07J53/00 , A61K31/705
Abstract: 4,5-methano-bufadienolide-rhamnosides of the formula I I where R1 is hydrogen or alkyl or acyl of 1 to 4 carbon atoms, R2 and R3 are identical or different and each is hydrogen or alkyl or acyl of 1 to 4 carbon atoms, or both together are where R4 and R5 are identical or different and each is hydrogen or alkyl or alkoxy of 1 or 2 carbon atoms. The novel compounds may be used for counteracting cardiac insufficiency.
-
公开(公告)号:DE3825561A1
公开(公告)日:1990-02-01
申请号:DE3825561
申请日:1988-07-28
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , PHILIPSBORN GERDA VON DR MED
IPC: C07D209/08 , A61K31/135 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/415 , A61K31/445 , A61K31/495 , A61P9/06 , C07C217/22 , C07D207/32 , C07D207/323 , C07D207/333 , C07D209/12 , C07D231/12 , C07D295/08 , C07D295/092 , C07D333/22
Abstract: Abstract of the disclosure: p-hydroxy phenone derivatives of the formula I I where X is where R1=F, Cl, Br or trifluoromethyl or a heteroaryl of the structure +TR with R2=C1-C4-alkyl, Y is a bridging member of the formula -CH=CH-, -CH2CH2- or -CH2-, is one of the numbers 2, 3 or 4 and is an amino group of the formula -NR2R3 or N-pyrrolidyl or N-piperidyl, where R2 and R3 are, independently of one another, C1-C4-alkyl, as well as the physiologically tolerated salts thereof, are used for preparing antiarrhythmic drugs.
-
-
-
-
-
-
-
-
-